Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase

BACKGROUND: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of endothelial nitric oxide synthase (eNOS), is considered a risk factor for the pathogenesis of cardiovascular diseases. Simvastatin, a lipid‐lowering drug with other pleiotropic effects, has been widely used for treatment of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chiao‐Po, Zhao, Jin‐Feng, Lin, Shing‐Jong, Shyue, Song‐Kun, Guo, Bei‐Chia, Lu, Tse‐Min, Lee, Tzong‐Shyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843600/
https://www.ncbi.nlm.nih.gov/pubmed/27091343
http://dx.doi.org/10.1161/JAHA.116.003327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843600/
https://www.ncbi.nlm.nih.gov/pubmed/27091343
http://dx.doi.org/10.1161/JAHA.116.003327

Ejemplares similares